Compare the physiologic responses of the respiratory system to emphysema, chronic bronchitis, and asthma



Similar documents
2.06 Understand the functions and disorders of the respiratory system

Breathe Easy: Asthma and FMLA

The Annual Direct Care of Asthma

COPD PROTOCOL CELLO. Leiden

understanding the professional guidelines

PATIENT INFORMATION ABOUT TREATMENTS FOR ASTHMA AND ALLERGIC RHINITIS, PRESCRIPTIONS & OVER THE COUNTER MEDICINE

Tests. Pulmonary Functions

YOU VE BEEN REFERRED TO AN ASTHMA SPECIALIST...

ASTHMA IN INFANTS AND YOUNG CHILDREN

Your Lungs and COPD. Patient Education Pulmonary Rehabilitation. A guide to how your lungs work and how COPD affects your lungs

Treatment of Asthma. Talk to your doctor about the various medications available to treat asthma.

written by Harvard Medical School COPD It Can Take Your Breath Away

RSPT 2317 Non-steroidal anti-asthma agents

DRUG UTILISATION STUDY IN BRONCHIAL ASTHMA IN A TERTIARY CARE HOSPITAL

Asthma Glossary. Allergen

Chronic obstructive pulmonary disease (COPD)

COPD It Can Take Your Breath Away

Assessing the Asthmatic Airway Written by Lindell Forbes EMT-P

Pulmonary Disorders. Chronic Obstructive Pulmonary Disease (COPD) Chronic Obstructive Pulmonary Disease (COPD)

RESPIRATORY VENTILATION Page 1

On completion of this chapter you should be able to: discuss the stepwise approach to the pharmacological management of asthma in children

Prof. Florian Gantner. Vice President Respiratory Diseases Research Boehringer Ingelheim

COPD. Information brochure for chronic obstructive pulmonary disease.

Objectives COPD. Chronic Obstructive Pulmonary Disease (COPD) 4/19/2011

From the Text. Clinical Indications. Clinical Indications. RSPT 2217 Non-steroidal Anti-asthma Agents. RSPT 2317 Non-steroidal Antiasthma Agents

Pre-Operative Services Teaching Rounds 2 Jan 2011

Medications for Managing COPD in Hospice Patients. Jim Joyner, PharmD, CGP Director of Clinical Operations Outcome Resources

Pharmacology of the Respiratory Tract: COPD and Steroids

Classifying Asthma Severity and Initiating Treatment in Children 0 4 Years of Age

The asthmatic patient and sedation

Medicines Use Review Supporting Information for Asthma Patients

II. ASTHMA BASICS. Overview of Asthma. Why do I need to know about asthma?

Documenting & Coding. Chronic Obstructive Pulmonary Disease (COPD) Presented by: David S. Brigner, MLA, CPC

medicineupdate to find out more about this medicine

inability to take a deep breath)

Asthma Care. Of course, your coach is there to answer any questions you have about your asthma, such as:

5. Treatment of Asthma in Children

Background information

The Right Medicines Can Help You Get Control of Asthma. BlueCare SM TennCareSelect

Understanding Asthma Patients in the Dental Office

Drug therapy SHORT-ACTING BETA AGONISTS SHORT-ACTING ANTICHOLINERGICS LONG-ACTING BETA AGONISTS LONG-ACTING ANTICHOLINERGICS

Medication and Devices for Chronic Obstructive Pulmonary Disease (COPD)

COPD. What is COPD? How many people have COPD in Canada? Who gets COPD?

Protocol in depth Asthma/COPD.

Asthma in Infancy, Childhood and Adolescence. Presented by Frederick Lloyd, MD Palo Alto Medical Foundation Palo Alto, California

Sponsor Novartis Pharmaceuticals

Management of Asthma

RSPT 1410 Common Respiratory Drugs

EMPHYSEMA THERAPY. Information brochure for valve therapy in the treatment of emphysema.

COPD and Asthma Differential Diagnosis

ACTIVITY #3: LUNG HEALTH ASTHMA AND ALLERGIES

What You Should Know About ASTHMA

MILITARY (ACTIVE DUTY)-SPECIFIC ISSUES

GEORGIA MEDICAID FEE-FOR-SERVICE ASTHMA and COPD AGENTS PA SUMMARY

CHAPTER 1: THE LUNGS AND RESPIRATORY SYSTEM

F r e q u e n t l y As k e d Qu e s t i o n s. Lung Disease

Treatments for allergy are usually straightforward, safe and effective. Common treatments include:

PRINCE Structured Education Programme Part One Practice Nurses Educators Manual

Cough, as a leading symptom, would certainly be in the top 10 of reasons for seeing a GP.

Key Points. Autonomic Nervous System Drugs. Autonomic effects Sympathetic. Drugs can modify ANS activity by: Autonomic Nervous System

These factors increase your chance of developing emphysema. Tell your doctor if you have any of these risk factors:

Strategies for Improving Patient Outcomes in Pediatric Asthma Through Education. Pediatric Asthma. Epidemiology. Epidemiology

against allergic symptoms thought to be histaminic during a period of 1% minutes. No side effects When a dose of 30 mgm. of benadryl in 50 ml.

You think its mucus but it s not! By John R. Goodman BS RRT

Respiratory Disorders

IN-HOME QUALITY IMPROVEMENT. BEST PRACTICE: DISEASE MANAGEMENT Chronic Obstructive Pulmonary Disease NURSE TRACK

Gas Exchange Graphics are used with permission of: adam.com ( Benjamin Cummings Publishing Co (

Asthma Definition. Relationship of Airway Inflammation and Lung Function

Montelukast Sodium. -A new class of seasonal allergic rhinitis therapy

An Overview of Asthma - Diagnosis and Treatment

A. All cells need oxygen and release carbon dioxide why?

Information for Behavioral Health Providers in Primary Care. Asthma

Influenza (Flu) Influenza is a viral infection that may affect both the upper and lower respiratory tracts. There are three types of flu virus:

Salbutamol 1mg/ml Nebuliser Solution. Salbutamol 2mg/ml Nebuliser Solution PL 36390/0035 PL 36390/0036

Gas Exchange. Graphics are used with permission of: Pearson Education Inc., publishing as Benjamin Cummings (

How to use FENO-guided asthma control in routine clinical practice

Asthma and COPD Awareness

RES/006/APR16/AR. Speaker : Dr. Pither Sandy Tulak SpP

EMS Information Bulletin- #060

Emphysema. Introduction Emphysema is a type of chronic obstructive pulmonary disease, or COPD. COPD affects about 64 million people worldwide.

Understanding COPD. Carolinas Healthcare System

Population Health Management Program

COPD Intervention. Components:

Childhood Asthma / Wheeze

DRUG INTERACTIONS: WHAT YOU SHOULD KNOW. Council on Family Health

T HE ROLE OF THE PHARMACIST IN IMPROVING ASTHMA CARE NIH PUBLICATION NO JULY 1995 NATIONAL INSTITUTES. National Heart, Lung,

Drugs for treatment of respiratory diseases. Huifang Tang Department of pharmacology Zhejiang University, school of medicine

CHRONIC OBSTRUCTIVE PULMONARY DISEASE. Includes: Bronchitis (chronic and acute) Emphysema

GCE AS/A level 1661/01A APPLIED SCIENCE UNIT 1. Pre-release Article for Examination in January 2010 JD*(A A)

Your Go-to COPD Guide

Respiratory Care. A Life and Breath Career for You!

Recurrent or Persistent Pneumonia

Human Anatomy and Physiology The Respiratory System

Understanding and Controlling Asthma Attacks. Information for parents

Living Well With COPD Chronic Bronchitis and Emphysema

Seasonal Allergies The Patient Education Institute, Inc. im Last reviewed: 05/30/2012 1

CERVICAL MEDIASTINOSCOPY WITH BIOPSY

Inhaled and Oral Corticosteroids

InetCE H01

Transcription:

Chapter 31 Drugs Used to Treat Lower Respiratory Disease Learning Objectives Describe the physiology of respirations Compare the physiologic responses of the respiratory system to emphysema, chronic bronchitis, and asthma Identify components of blood gases Distinguish the mechanisms of action of expectorants, antitussives, and mucolytic agents Lower Respiratory Tract Anatomy and Physiology Larynx Trachea Bronchus Arterioles Bronchiole Alveolus The Respiratory Tract and the Alveoli Common Lower Respiratory Diseases Chronic obstructive pulmonary disease (COPD) Chronic airflow limitation disease (CALD) Asthma Chronic bronchitis

Emphysema Drug Therapy for Lower Respiratory Diseases Expectorants Antitussives Mucolytic agents Antiinflammatory agents Immunomodulators Learning Objectives Cite nursing assessments used to evaluate the respiratory status of a patient Review the procedures for administration of medication by inhalation Implement patient education for patients receiving drug therapy for lower respiratory disease Learning Objectives (cont d) State the nursing assessments needed to monitor therapeutic response and the development of side effects to expect or report from expectorant, antitussive, and mucolytic therapy Nursing Process for Lower Respiratory Disease Assessment History, description, medications, description of current symptoms, respiratory assessment, inspection, palpation Planning

Medications, hydration, respiratory and cardiovascular assessment, laboratory/diagnostic studies Implementation Patient Education and Health Promotion Understand how to use peak flowmeter Avoid irritants Adjust physical activity Adjust nutritional patterns Prevent infections Increase fluid intake Expectorants: Guaifenesin Actions: enhances output of respiratory tract fluid Uses: relieves dry, nonproductive cough Removes mucous plugs from respiratory tract Therapeutic outcomes: reduced frequency of nonproductive cough Nursing process for guaifenesin : record cough characteristics : tablets and liquids and drug interactions Expectorants Potassium iodide

Actions: increases bronchial gland secretions Uses: treats chronic pulmonary diseases Therapeutic outcomes: reduces mucus viscosity Nursing process for potassium iodide : record cough characteristics, note pregnancy : liquid Evaluation: expected side effects Expectorants: Saline Solutions Actions Hydrates mucus, reduces viscosity Uses Effective expectorants when administered by nebulization Therapeutic outcomes Moisturized mucous membranes Antitussive Agents Actions: suppress cough center in brain Uses: suppress disruptive spasms Therapeutic outcomes: reduce coughs Nursing process for antitussive agents : record characteristics of cough : capsules, tablets, syrup, liquid, drug interactions

Mucolytic Agents: Acetylcysteine Actions: dissolves chemical bonds in mucus Uses: dissolves abnormally viscous mucus In chronic emphysema, emphysema with bronchitis, asthmatic bronchitis, pneumonia Therapeutic outcomes: improved airway flow Nursing process for acetylcysteine therapy : record baseline vital signs, drug interactions Beta Adrenergic Bronchodilators Actions: stimulate beta receptors within smooth muscle of tracheobronchial tree Uses: reverse airway constriction Mainstay of all asthma therapy Therapeutic outcomes: easier breathing Nursing process for beta adrenergic bronchodilators Anticholinergic Bronchodilating Agents: Ipratropium Bromide Actions: produces bronchodilation by competitive inhibition of cholinergic receptors on bronchial smooth muscle

Uses: long-term treatment of reversible bronchospasm associated with COPD Therapeutic outcomes: easier breathing Nursing process for sympathomimetic bronchodilators Anticholinergic Bronchodilating Agents: Tiotropium Bromide Administered by aerosol inhalation Produces bronchodilation by competitive inhibition of cholinergic receptors on bronchial smooth muscle Longer in duration of action than ipratropium Used once daily for long-term treatment of reversible bronchospasm associated with COPD, including bronchitis and emphysema Xanthine-Derivative Bronchodilating Agents Actions: act on tracheobronchial tree to dilate bronchi Uses: reverse airway constriction Therapeutic outcomes: easier breathing Nursing process for xanthine-derivative bronchodilating agents : obtain, record baseline vital signs, drug interactions

Respiratory Antiinflammatory Agents: Corticosteroids Actions: treat obstructive lung disease Uses: given to patients unresponsive to sympathomimetic agents or xanthine derivatives Therapeutic outcomes: easier breathing with less effort Nursing process for corticosteroids : inspect oral cavity for infection Antileukotriene Agents: Montelukast-Singulair Actions: selective and competitive receptor antagonist of cysteinyl leukotriene receptor Uses: with other medications to treat asthma Therapeutic outcomes: reduces acute asthma Nursing process for montelukast : obtain, record baseline vital signs : tablets Antileukotriene Agents: Zafirlukast-Accolate Actions: selective and competitive receptor antagonist of the cysteinyl leukotriene receptor Uses: with other medications for asthma Therapeutic outcomes: fewer episodes of acute asthmatic symptoms

Nursing process for zafirlukast Immunomodulators: Omalizumab Actions: inhibits chemicals that can lead to asthma Uses: patients at least 12 years with asthma with a positive skin test to airborne allergens Therapeutic outcomes: reduced frequency of acute asthmatic exacerbations Nursing process for omalizumab : determine allergy history : dissolve powder for subcutaneous injection Miscellaneous Antiinflammatory Agents: Cromolyn Sodium-Intal Actions: inhibits release of histamines and other mediators of inflammation Uses: treats patients with severe bronchial asthma or allergic rhinitis Therapeutic outcomes: reduced asthmatic attacks Nursing process for cromolyn sodium

Miscellaneous Antiinflammatory Agents: Nedocromil Sodium-Tilade Actions: prevents release of histamines and other mediators that cause inflammation Uses: treats patients with bronchial asthma Therapeutic outcomes: fewer episodes of acute asthmatic symptoms Nursing process for nedocromil sodium